Results 241 to 250 of about 887,943 (333)

Engineering antibodies with cancer‐associated binding sites

BMEMat, EarlyView.
This review describes antibodies that perform direct/indirect roles in cancer treatment by binding to effective targets and discusses how antibodies kill tumors and modulate tumor microenvironment through these targets. The classification of expression systems for antibody production is summarized to guide appropriate selection based on different ...
Yinqi Tian, Yumeng Pan, Yingchun Zhang, Fangling Wang, Zejun Wang   +4 more
wiley   +1 more source

Diagnostic value of circular RNAs as promising hematological biomarkers in acute myeloid leukemia: A systematic review and meta-analysis. [PDF]

J Res Med Sci
Aghayan AH, Mirazimi Y, Hosseini ZS, Rafiee M.   +3 more
europepmc   +1 more source

Outcomes of Post‐Transplant Rh‐GCSF and Decitabine Maintenance Therapy in Patients With High‐Risk Myeloid Neoplasm

American Journal of Hematology, EarlyView.
Mathias Palmer, Anmol Baranwal, Rami Basmaci, Khalil Hassan, Jade Kutzke, Gabriel Bartoo, Hemant Murthy, James Foran, Abhishek A. Mangaonkar, Mehrdad Hefazi, Aasiya Matin, William J. Hogan, Mark Litzow, Mithun Vinod Shah, Hassan B. Alkhateeb   +14 more
wiley   +1 more source

Associations of body mass index and waist circumference with incidence of overall and of 27 site‐specific cancers: a population‐based retrospective cohort study

Cancer Communications, EarlyView.
Abstract Background Overweight and obesity are known risk factors for cancer. The aim of this study was to investigate associations of body mass index (BMI) and waist circumference (WC) with incidence of 27 site‐specific cancers stratified by sex and menopausal status accounting for non‐linearity.
Seonghye Kim, Bongseong Kim, Kyu‐won Jung, Ga Eun Nam, Wonyoung Jung, Junhee Park, Kyung‐Do Han, Dong Wook Shin   +7 more
wiley   +1 more source

Extramedullary Involvement in T/Myeloid Mixed Phenotype Acute Leukemia With BCR::ABL1 Fusion in a Hispanic Female Patient: A Case Report. [PDF]

Cureus
Santiago-Negron CL, Cordero Hernández JM, Marrero-León WD, Rivera Rolón MD.   +3 more
europepmc   +1 more source

Targeting PR1 in myeloid leukemia

Oncotarget, 2017
Gheath Alatrash, Muzaffar H. Qazilbash, Jeffrey J. Molldrem   +2 more
openaire   +3 more sources

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Nature Network Boston, 2018
D. Pollyea, Brett M. Stevens, Courtney L Jones, Amanda C. Winters, Shanshan Pei, Mohammad Minhajuddin, A. D’Alessandro, Rachel Culp-Hill, K. Riemondy, A. Gillen, J. Hesselberth, Diana Abbott, Derek Schatz, J. Gutman, E. Purev, Clayton A. Smith, C. Jordan   +16 more
semanticscholar   +1 more source

Efficacy and Safety of the Third‐Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation

American Journal of Hematology, EarlyView.
Xiaoyu Zhang, Yigeng Cao, Jialin Wei, Weihua Zhai, Qiaoling Ma, Chen Liang, Xin Chen, Wenbin Cao, Donglin Yang, Aiming Pang, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang   +14 more
wiley   +1 more source

Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47

Cancer Communications, EarlyView.
Abstract Background Only a few bladder cancer patients benefit from anti‐programmed cell death protein 1/programmed cell death ligand 1 immunotherapy. The cluster of differentiation 47 (CD47) plays an important role in tumor immune evasion. CD47 is a highly glycosylated protein, however, the mechanisms governing CD47 glycosylation and its potential ...
Jie Zhang, Chen Zhang, Ruichen Zang, Weiwu Chen, Yining Guo, Haofei Jiang, Jing Le, Kunyu Wang, Haobo Fan, Xudong Wang, Sisi Mo, Peng Gao, Wenhao Guo, Xinrong Jiang, Fengbin Gao, Junming Jiang, Juyan Zheng, Yuxing Chen, Yicheng Chen, Yanlan Yu, Guoqing Ding   +20 more
wiley   +1 more source

Targeting PD-1 for HCT relapse: an immunologic knife's edge. [PDF]

Blood Adv
Shapiro RM, Soiffer RJ.
europepmc   +1 more source